Product Information
SUCRALFATE 1 GM/10 ML SUSP is a generic product labeled by Strides Pharma Inc., priced at $0.1209 per ML under NDC 64380014901. Its NADAC has been published 103 times since Sep 4, 2024.
FDA first approved this application on May 21, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/10mL
Manufacturer
Strides Pharma Inc.NDC
64380014901
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SUCRALFATEApproval Type
Generic (ANDA)
FDA Application
ANDA216474FDA Approved
5/21/2024
TE Code
AB
On Market Since
7/10/2024
Pharmacological Classes
Price Statistics
The NADAC for SUCRALFATE 1 GM/10 ML SUSP has been published 103 times since Sep 4, 2024, and over the history we have for it it has declined 50.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1209 per ML |
|---|---|
| All-time high | $0.2598 (Oct 16, 2024) |
| All-time low | $0.1153 (Jul 22, 2026) |
| 52-week high | $0.1253 |
| 52-week low | $0.1153 |
| Median price | $0.1250 |
| Average price | $0.1590 |
| Largest weekly change | -14.7% (Feb 19, 2025) |
| Weeks tracked | 103 |
| Tracking since | Sep 4, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SUCRALFATE 1 GM/10 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM/10 ML SUSP, manufactured by Strides Pharma Inc., is $0.1209 per ML (NDC 64380014901), effective Aug 19, 2026.
How has the price of SUCRALFATE 1 GM/10 ML SUSP changed over time?
Over the history we have for it, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has declined 50.3%. It has been tracked across 103 weekly CMS publications since Sep 4, 2024.
What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM/10 ML SUSP?
Since Sep 4, 2024, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has ranged from a low of $0.1153 (Jul 22, 2026) to a high of $0.2598 (Oct 16, 2024), with a median of $0.1250 per ML.
Are there cheaper alternatives to SUCRALFATE 1 GM/10 ML SUSP?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUCRALFATE 1 GM/10 ML SUSP, is $0.1129 per ML — about 7% below SUCRALFATE 1 GM/10 ML SUSP.
Who manufactures SUCRALFATE 1 GM/10 ML SUSP?
SUCRALFATE 1 GM/10 ML SUSP (NDC 64380014901) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.